Shenzhen Salubris Pharmaceuticals Co Ltd Net Asset Quality Index
Shenzhen Salubris Pharmaceuticals Co Ltd net asset quality index. Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Net Asset Quality Index of 81.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥10.98 Billion minus total liabilities of CN¥2.05 Billion yields net assets of CN¥8.93 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check cash flow quality index of Shenzhen Salubris Pharmaceuticals Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Net asset quality index of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. This chart shows how Shenzhen Salubris Pharmaceuticals Co Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2006 to 2024. As of September 2025, the index stands at 81.3%, representing net assets of CN¥8.93 Billion against total assets of CN¥10.98 Billion CNY. See shareholders equity of Shenzhen Salubris Pharmaceuticals Co Ltd for net asset value and shareholders' equity analysis.
Shenzhen Salubris Pharmaceuticals Co Ltd Net Asset Quality Index by Year (2006–2024)
Shenzhen Salubris Pharmaceuticals Co Ltd net asset quality index by year from 2006 to 2024. The table below presents the year-by-year Net Asset Quality Index for Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002294 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 83.6% | CN¥8.75 Billion | CN¥10.47 Billion | CN¥1.71 Billion | ▼ -2.1 pp |
| 2023 | 85.7% | CN¥8.06 Billion | CN¥9.40 Billion | CN¥1.34 Billion | ▲ +4.0 pp |
| 2022 | 81.8% | CN¥7.98 Billion | CN¥9.76 Billion | CN¥1.78 Billion | ▼ -5.3 pp |
| 2021 | 87.0% | CN¥8.05 Billion | CN¥9.24 Billion | CN¥1.20 Billion | ▲ +6.2 pp |
| 2020 | 80.8% | CN¥5.59 Billion | CN¥6.92 Billion | CN¥1.33 Billion | ▼ -5.4 pp |
| 2019 | 86.2% | CN¥6.67 Billion | CN¥7.73 Billion | CN¥1.07 Billion | ▼ -0.7 pp |
| 2018 | 86.9% | CN¥6.87 Billion | CN¥7.90 Billion | CN¥1.03 Billion | ▼ -2.8 pp |
| 2017 | 89.7% | CN¥6.16 Billion | CN¥6.86 Billion | CN¥705.86 Million | ▲ +6.2 pp |
| 2016 | 83.6% | CN¥5.46 Billion | CN¥6.53 Billion | CN¥1.07 Billion | ▼ -3.6 pp |
| 2015 | 87.2% | CN¥4.70 Billion | CN¥5.39 Billion | CN¥691.25 Million | ▲ +5.1 pp |
| 2014 | 82.1% | CN¥3.79 Billion | CN¥4.62 Billion | CN¥827.95 Million | ▼ -4.0 pp |
| 2013 | 86.0% | CN¥3.13 Billion | CN¥3.64 Billion | CN¥508.36 Million | ▼ -1.4 pp |
| 2012 | 87.5% | CN¥2.61 Billion | CN¥2.98 Billion | CN¥374.02 Million | ▲ +0.2 pp |
| 2011 | 87.3% | CN¥2.13 Billion | CN¥2.45 Billion | CN¥310.52 Million | ▲ +1.5 pp |
| 2010 | 85.8% | CN¥1.87 Billion | CN¥2.17 Billion | CN¥309.50 Million | ▼ -5.8 pp |
| 2009 | 91.6% | CN¥1.62 Billion | CN¥1.77 Billion | CN¥148.59 Million | ▲ +27.3 pp |
| 2008 | 64.3% | CN¥262.90 Million | CN¥408.60 Million | CN¥145.70 Million | ▲ +7.3 pp |
| 2007 | 57.0% | CN¥145.96 Million | CN¥255.94 Million | CN¥109.98 Million | ▼ -10.1 pp |
| 2006 | 67.1% | CN¥106.48 Million | CN¥158.66 Million | CN¥52.19 Million | — |